Paricalcitol-treated patients experience improved hospitalization outcomes compared with calcitriol-treated patients in real-world clinical settings.

@article{Dobrez2004ParicalcitoltreatedPE,
  title={Paricalcitol-treated patients experience improved hospitalization outcomes compared with calcitriol-treated patients in real-world clinical settings.},
  author={Deborah G. Dobrez and Angelo Mathes and Michael J. Amdahl and Steven E. Marx and Joel Z. Melnick and Stuart M. Sprague},
  journal={Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association},
  year={2004},
  volume={19 5},
  pages={1174-81}
}
BACKGROUND Abnormalities of serum calcium, phosphorous and intact parathyroid hormone (PTH) are associated with morbidity and mortality in haemodialysis patients. Pharmacologic parenteral vitamin D administration is used to correct these abnormalities; however, the relationship between vitamin D therapies and hospitalizations has never been addressed. METHODS Healthcare data from January 1999 to November 2001 were analysed for 11,443 adult haemodialysis patients who received at least 10 doses… CONTINUE READING

From This Paper

Figures, tables, results, connections, and topics extracted from this paper.
36 Extracted Citations
0 Extracted References
Similar Papers

Citing Papers

Publications influenced by this paper.
Showing 1-10 of 36 extracted citations

Similar Papers

Loading similar papers…